Table 3.
Comparison of rediscoveries with other approaches for Magnesium – Migraine
| Scenario | Intermediate(s) | Cameron | Srinivasan [7] |
Weeber [4] |
Blake [37] |
Gordon [3] |
|||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | P | S | P | S | P | S | P | S | P | ||
| Magnesium - Migraine |
Calcium Channel Blockers | Y | 22 | Y | 3 | Y | - | Y | 10 | Y | 1 |
| Epilepsy | Y* | 9 | - | - | Y | - | Y | 8 | Y | 3 | |
| Hypoxia | - | - | Y | 5 | - | - | Y | 6 | Y | 77 | |
| Inflammation | Y* | ZR-3 | Y | 2 | Y | - | Y | 170 | Y | 82 | |
| Platelet Activity | Y* | 1 | Y | 2 | Y | - | Y | 2 | Y | 8 | |
| Prostaglandins | Y | 4 | Y | 1 | Y | - | Y | 42 | Y | 27 | |
| Stress/Type A Personality | - | - | Y | 1 | Y | - | Y | 23 | - | - | |
| Serotonin | Y | 1 | Y | 1 | Y | - | Y | 5 | Y | 1 | |
| Spreading Cortical Depression | - | - | Y | 6 | - | - | Y | 45 | - | - | |
| Substance P | - | - | Y | 18 | Y | - | Y | 38 | Y | 23 | |
| Vascular Mechanisms | Y | 9 | Y | 1 | Y | - | Y | 46 | Y | 16 | |